Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Trends in thromboembolism-related mortality among patients with hematologic malignancies in the u.S., 1999–2023: A CDC wonder analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

AIAhmad Iftikhar

Discussion

Loading...

Member takes

Overview

Analysis shows increased thromboembolism-related mortality in hematologic malignancies, highlighting the need for improved preventive care and risk stratification.

Key Points

  • Mortality rates from thromboembolism increased sharply among hematologic malignancies, reflecting significant demographic disparities.
  • In 19,324 cases from 1999 to 2023, trends showed varied rates by region, age, and race, with non-Hispanic Blacks most affected.
  • Joinpoint regression analysis revealed a significant rise in mortality from 2018 to 2021, likely influenced by the COVID-19 pandemic.
  • Addressing disparities in thromboembolism outcomes emphasizes the importance of risk stratification and enhanced preventive care.

Cite This Study

Ahmad Iftikhar (2025) studied this question.

synapsesocial.com/papers/69362f4e4fa91c937236d8e7https://doi.org/10.1182/blood-2025-6610
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Temporal trends in cancer-associated venous thromboembolism mortality: A nationwide analysis (1999–2020)2025
  2. 2Trends and disparities in premature mortality from hematologic malignancies: Analysis of CDC wonder data, 1999-20202025
  3. 3Temporal trends in mortality from hematological cancers with atrial fibrillation and flutter as contributing causes in the United States, 2000–2020: A national vital statistics system analysis2025
  4. 4National trends in sudden cardiac death among patients with hematologic malignancies in the United States: CDC analysis, 1999–2023.2026
  5. 5Trends in ischemic stroke and ischemic heart disease-related mortality among patients with malignancies in the United States: A 25-year CDC-WONDER analysis (1999-2023).2026